4 completed. 2 Phase 1, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Peptide T: new trials by email Literature Review of Peptide T trials Research Report on Peptide T
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment. Peptide T, Placebo - HIV Infections, Cognition Disorders | Phase 2 | Completed | National Institute of Mental Health (NIMH) | 215 | 1990-01-01 | 2017-02-28 |
| A Phase I Trial of Intranasal Peptide T: Safety, Toxicity, and Pharmacokinetics in Human Immunodeficiency Virus-1 (HIV-1) Infected Patients. Peptide T - HIV Infections | Phase 1 | Completed | National Institute of Mental Health (NIMH) | 30 | 1988-01-01 | 2015-03-03 |
| A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS). Peptide T - HIV Infections, Cognition Disorders | Phase 1 | Completed | National Institute of Mental Health (NIMH) | 6 | 1988-01-01 | 2015-03-02 |
| Intranasal Peptide T in the Treatment of Painful Peripheral Neuropathy of AIDS Peptide T - HIV Infections, Peripheral Nervous System Disease | Not applicable | Completed | Advanced Peptides | 2005-06-24 |
Acquired Immunodeficiency Syndrome (4) · HIV Infections (4) · AIDS-Related Complex (2) · Cognition Disorders (2) · Peripheral Nervous System Diseases (1)
National Institute of Mental Health (NIMH) (3) · Advanced Peptides (1)
United States (4)
Bridge TP (2)